Skip to Main

Search

Results 1 to 10 of 1,030 for ""

Radiation Oncology campus in Fort Worth marks construction milestone: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2026/nov-radiation-oncology-campus.html

Fort Worth took a major step forward today toward a new era in advanced cancer care as UT Southwestern and community leaders gathered to celebrate the placing of the final beam atop the $177 million Radiation Oncology campus rising in the city’s Medical District.

New pediatric campus in Dallas reaches major construction milestone: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2026/sept-pediatric-campus-construction-milestone.html

Watching the new pediatric campus created by Children’s Health and UT Southwestern Medical Center rise in Dallas’ Southwestern Medical District holds special meaning for Cameron Strother.

A decade of excellence: UTSW is DFW’s top hospital for 10th year in a row: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2026/aug-usnwr-best-hospital.html

For the 10th consecutive year, UT Southwestern Medical Center has been named the No. 1 hospital in Dallas-Fort Worth by U.S. News & World Report. Additionally, UTSW ranks among the nation’s top hospitals for care in 11 specialties – the most of any hospital in Texas – in the annual U.S. News Best Hospitals list released today.

News Releases: Newsroom - UT Southwestern, Dallas, TX

https://www.utsouthwestern.edu/newsroom/articles/

Read past stories about the extraordinary work being done and the passionate people behind it.

Media Relations: Newsroom - UT Southwestern

https://www.utsouthwestern.edu/newsroom/media-relations/

Information for media relations with UT Southwestern

Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/

UT Southwestern Communications tells stories about the extraordinary work being done here every day and about the dedicated, passionate people behind it. Explore these stories.

O’Donnell Foundation marks nearly $400 million in support for UT Southwestern with final gift: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2026/oct-odonnell-foundation-gift.html

The O’Donnell Foundation’s legacy of support for UT Southwestern Medical Center will reach nearly $400 million with a capstone gift of its remaining assets, completing more than half a century of philanthropy that has advanced biomedical discovery, medical education, and patient care.

FDA approval of belzutifan culminates 25-year journey at UTSW from gene discovery to a first-in-class drug: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/fda-approval-belzutifan.html

A first-in-kind kidney cancer drug developed from laboratory and translational studies conducted at UT Southwestern Medical Center received approval from the Food and Drug Administration, providing a new treatment for patients with familial kidney cancer.

Children’s Research Institute scientists uncover unique pathway tumors use to acquire antioxidant lipids: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/june-cri-utsw-pathway-tumors-antioxidant-lipids.html

Scientists have discovered tumors can tap a nontraditional pathway to acquire lipoproteins – molecules that transport fat in blood – which enriches cancer cells with an antioxidant shield to survive stress, according to new research from Children’s Medical Center Research Institute at UT Southwestern (CRI) published in Nature.

Kidney cancer drug shows promise against dangerous calcium imbalance caused by tumors: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/oct-kidney-cancer-drug.html

Elevated calcium levels in the blood – a complication of kidney cancers known as hypercalcemia – may be successfully treated with a class of medications called HIF-2 inhibitors developed by UT Southwestern Medical Center, a new study shows. The findings, published in Cancer Discovery by a team at UTSW, could offer hope to patients who develop this condition.